Research Focus

Former Employee. MEDICINE; Clinical Research Coordinator

Recent additions – View all

1. A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis

   Meeting Abstract

   Sanchez, L.; Landau, H. J.; Rosenbaum, C. A.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
   Blood (2019)

   Fulltext@MSK | Save
2. A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis

   Meeting Abstract

   Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
   Clinical Lymphoma, Myeloma and Leukemia (2019)

   Fulltext@MSK | Save
3. Modified high-dose melphalan and autologous stem cell transplantation for immunoglobulin light chain amyloidosis

   Journal Article

   Nguyen, V. P.; Landau, H.; Quillen, K.; Brauneis, D.; Shelton, A. C.; Mendelson, L.; Rahman, H.; Sloan, J. M.; Sarosiek, S.; Sanchorawala, V.
   Biology of Blood and Marrow Transplantation (2018)

   Fulltext@MSK | Save